Researchers at Brigham and Women's Hospital and Harvard Medical School went through insurance claims for patients taking antiepileptic drugs and counted how many different-looking pills they had been handed. The answer was 37 colors and four shapes. A change in pill color was associated with 27 percent higher odds that a patient stopped refilling, the team reported in JAMA Internal Medicine in 20131.
The active ingredient and strength were the same. The pharmacy had filled the prescription with a version from a different manufacturer, which is routine in the generic market. Each maker designs its own tablet, and FDA lets them look different.
A change in appearance is still worth checking, and public tools make it possible to do that in a few minutes.
Why two versions of one generic look different
A generic has to match the brand on active ingredient, strength, dosage form and how it performs in the body. Appearance is a separate matter. "FDA generally allows minor differences in appearance between generic and brand drugs, such as in color," and "these minor differences do not affect how the medicine works," the agency's consumer Q&A says8. Small, allowable differences in inactive ingredients such as dyes, coatings and fillers are part of the reason, as our guide to what's actually different between generic and brand explains.
If five companies make the same generic, five different looks can sit on pharmacy shelves at once. Color is the most common difference, but shape, size, scoring and the printed code usually differ too. All of those versions can carry the same AB rating in FDA's Orange Book.
FDA does set expectations on size. In guidance finalized in October 20225, it recommends that when the brand tablet is under 17 mm in its largest dimension, a generic be no more than 20 percent larger in any single dimension and no more than 40 percent larger by volume. The guidance document6 also says the largest dimension of a tablet should not exceed 22 mm and capsules should not exceed a standard size 00. It says nothing requiring generics to match the brand's color.
Why the pharmacy changed suppliers
Pharmacies buy generics through wholesalers and purchasing contracts, and the supplier for a given drug can change from one order to the next. A new contract, a price change, a shortage at one manufacturer, a recall or a discontinued product can all trigger a switch. State substitution laws generally let the pharmacist dispense any version FDA rates as therapeutically equivalent, so the prescription doesn't need to be rewritten when the supplier changes.
For a common drug the choice of suppliers can be wide. GxRadar's drug pages show how many generic applications FDA has approved for each of 47 common medicines, and people who take the same drug for years may see several different-looking versions over that time.
The imprint code identifies the tablet
Federal regulation requires most solid oral drugs to carry a code, a rule traced in more detail in Pill imprint codes and the 1993 rule behind them. Under 21 CFR 206.103, a tablet or capsule may not be shipped in interstate commerce unless it is marked with an imprint that, "in conjunction with the product's size, shape, and color, permits the unique identification of the drug product and the manufacturer or distributor of the product." Identification means the active ingredients and the dosage strength. The rule encourages a letter or number "as a more effective means of identification than a symbol or logo by itself."
FDA published the rule in September 1993 and gave industry two years to retool, so it took effect on Sept. 13, 1995, according to a 1995 Federal Register clarification4. A small set of products are exempt.
Because of that rule, two pills that look nothing alike can be confirmed as the same drug and strength by checking each code against its official listing:
| Physical feature | What to note | Why it helps |
|---|---|---|
| Imprint code | Every letter, number and symbol on both sides | Required by 21 CFR 206.10 to identify the product and its maker |
| Color | Main color plus any second color on a capsule | Varies widely between manufacturers of the same drug |
| Shape | Round, oval, capsule-shaped, other | Listed on the official label for each product |
| Size | Approximate length in millimeters | FDA guidance asks generics to stay close to the brand's size |
| Score line | None, one line, or more | Recorded on the label; relevant if a tablet is meant to be split |
Checking a pill against its official listing
Start with the pharmacy label. It names the drug and strength, and many labels also show the National Drug Code or the manufacturer of the product dispensed. Our guide to reading a prescription label shows where to find them.
Next, look up the product in DailyMed9, the National Library of Medicine's database of FDA-submitted labeling. Each product's label page includes a Product Characteristics table listing color, score, shape, size in millimeters and imprint code. If you know which manufacturer's product you were given, you can compare the tablet in your hand with that listing.
Older tools are gone. NLM retired Pillbox, a federal pill identifier that let users search by imprint, color and shape, on Jan. 29, 2021. Its final data files "should not be used for pill identification," and MedlinePlus and DailyMed "do not provide pill identification," NLM's technical bulletin said7. DailyMed works best for confirming a pill you already have a name for.
The fastest check is the pharmacist. The pharmacy's dispensing record shows exactly which product went into your bottle, and the pharmacist can match the imprint in seconds.
What research says about appearance and adherence
Two widely cited studies from the same Boston research group looked at what happens after a pill's appearance changes:
| Study | Population | Finding |
|---|---|---|
| JAMA Internal Medicine, 2013 | 11,472 commercially insured patients who stopped refilling an antiepileptic drug, matched to 50,050 who kept refilling | Color change preceded 1.20% of stops versus 0.97% of controls; adjusted odds ratio 1.27. Among patients with a seizure diagnosis, 1.53. Shape changes were not statistically significant. |
| Annals of Internal Medicine, 2014 | 11,513 patients who started a generic beta-blocker, ACE inhibitor, ARB or statin after a heart attack (2006 to 2011) | 29% had a color or shape change. Odds of stopping rose 34% after a color change and 66% after a shape change. |
Both studies measured nonpersistence, meaning a patient failed to refill on time, rather than health outcomes. The 2014 paper listed among its limitations that "clinical outcomes were not addressed," and found that statins had the most appearance changes and beta-blockers the fewest, according to its abstract2. The 2013 authors argued that their findings support "a reconsideration of current regulatory policy that permits wide variation in the appearance of bioequivalent drugs," their abstract said. Statins such as atorvastatin and ACE inhibitors such as lisinopril belong to the drug classes in that heart study.
The likely mechanism is ordinary confusion. A patient who sees an unfamiliar tablet may suspect an error and set the bottle aside until someone explains it.
When to call the pharmacy
An unexplained change in appearance is a good reason to call. Pharmacists field this question constantly, and dispensing errors, while uncommon, do happen. Call if the imprint on the new tablets does not match what the label or DailyMed lists, if tablets in one bottle look different from each other, or if the strength on the label differs from what your prescriber told you.
Caregivers who sort pills into weekly organizers have a particular reason to keep the pharmacy's description handy, since tablets lose their bottle once they are sorted. Writing down each medicine's imprint code makes later checks quick. Any question about whether a new version is right for you, or about side effects after a switch, belongs with your pharmacist or prescriber.
Sources and notes
- Kesselheim AS et al. (2013). Variations in Pill Appearance of Antiepileptic Drugs and the Risk of Nonadherence. JAMA Internal Medicine 173(3):202-208 (PubMed abstract)
pubmed.ncbi.nlm.nih.gov/23277164/ - Kesselheim AS et al. (2014). Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction. Annals of Internal Medicine 161(2):96-103
pubmed.ncbi.nlm.nih.gov/25023248/ - Legal Information Institute (2026). 21 CFR 206.10, Code imprint required
www.law.cornell.edu/cfr/text/21/206.10 - Federal Register (1995). Imprinting of Solid Oral Dosage Form Drug Products for Human Use; Clarification
www.govinfo.gov/content/pkg/FR-1995-04-21/html/95-9951.htm - FDA (2022). Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules, guidance page
www.fda.gov/regulatory-information/search-fda-guidance-documents/size-shape-and-other-phys - FDA (2022). Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules, final guidance (PDF)
www.fda.gov/media/161902/download - NLM (2020). NLM to Retire Pillbox on January 29, 2021. NLM Technical Bulletin
www.nlm.nih.gov/pubs/techbull/ja20/ja20_pillbox_discontinue.html - FDA (2026). Generic Drugs: Questions and Answers
www.fda.gov/drugs/generic-drugs/questions-answers-generic-drugs - National Library of Medicine (2026). DailyMed
dailymed.nlm.nih.gov/dailymed/
Superscript numbers in the text link to these sources. GxRadar data (NADAC histories, recall and shortage counts) come from CMS and FDA files described on the sources page. Researched and drafted with AI assistance and checked against the sources above. Information current as of Nov 3, 2026 and may change. Spot an error? It will be corrected once confirmed.
Cited by
FDA's Inactive Ingredient Database and the limits on excipientsLook-alike and sound-alike drug names, and how FDA tries to keep them apartNarrow therapeutic index drugs and the tighter test for their genericsPill imprint codes and the 1993 rule behind themScored tablets and what the label says about themAuthorized generics are the brand drug under a generic labelHow to look up a drug on DailyMedHow to read a prescription labelStore-brand OTC medicinesThe NDC number explained, from 10 digits to 12The pharmacist's role in generic substitutionWhat a generic must share with its brand, and what can differWhat therapeutic equivalence codes like AB, AA and BX meanA script for talking to your pharmacist about priceMail-order pharmacy basicsGeneric drug labeling, skinny labels and carve-outsContract manufacturing in generic drugs, and who actually makes the pillNot health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation. Laws, prices and program rules described here can change; confirm current details with the official source.